Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers
NCT ID: NCT04599270
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
700 participants
INTERVENTIONAL
2021-10-01
2027-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A meta-analysis on the impact of this prevention programs in school settings, concluded that most interventions are associated with no or little impact with respect to the goal of reducing psychoactive substances with teenagers.
Among existing programs, "PREVENTURE" has been evaluated in 5 trials with high-risk teenagers identified in schools settings, in different countries (Canada, Europe). The results show a clear and robust effect on reducing alcohol consumption. This program has not been tested outside the school setting and a recent review mention the need to make this program more accessible by targeting vulnerable groups and studying the impact of this program on this population.
The PREVADO study is a prospective, controlled, randomised, open-label study. After inclusion, the adolescent completes the questionnaire SURPS (Substance Use Risk Profile Scale).
The SURPS is self-report questionnaire that assesses four well-validated personality risk factors for substance misuse (Impulsivity, Sensation Seeking, Anxiety Sensitivity, and Hopelessness). There is a 23-item to which adolescents are asked to respond using a 4-point Likert scale ranging from "strongly agree" to "strongly disagree" : Hopelessness (7 items), Anxiety Sensitivity (5 items), Impulsivity (5 items), and Sensation Seeking (6 items).
Adolescents will be randomized into 2 groups (stratification on the 4 predominant risk personality types from the SURPS (Substance Use Risk Profile Scale) and on the recruitment modality) :
* Intervention group : teenagers follow the "PREVENTURE" program and routine cares
* Control group : teenagers follow routine cares
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Teenager encounter psychologist for conduct a Substance Use risk Personality Scale (SURPS) assessment to identify personality characteristics that represent a risk for the development of problematic substance use. Only adolescents with at-risk personality traits according to the SURPS will be randomized for further assessment.
If adolescent have not risk personality traits, the patient will go out of the study.
If adolescent have risk personality traits, other tests and scales will be performed to study the intensivity of dependance of substance use and the patient will be randomized.
If he is randomized in intervention group, the patient will follow PREVENTURE program (2 session of 90 min by videoconference), within 3 months after inclusion and will be contacted by phone by the psychologist at 1, 3, 6 and 12 month after sessions to answer the same tests and scales.
PREVENTURE Program
Adolescents will be follow PREVENTURE program (2 session of 90 min).
Control group
Teenager encounter psychologist for conduct a Substance Use risk Personality Scale (SURPS) assessment to identify personality characteristics that represent a risk for the development of problematic substance use. Only adolescents with at-risk personality traits according to the SURPS will be randomized for further assessment.
If adolescent have not risk personality traits, the patient will go out of the study.
If adolescent have risk personality traits, other tests and scales will be performed to study the severity of substance use disorders and the patient will be randomized.
If he is randomized in control group, the patient will follow routine care and will be contacted by phone by the psychologist at 1, 3, 6 and 12 month after inclusion to answer the same tests and scales.
Routine care
Adolescents will be follow routine care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PREVENTURE Program
Adolescents will be follow PREVENTURE program (2 session of 90 min).
Routine care
Adolescents will be follow routine care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consulting in one of the participating centres or referred by a school doctor
* Patient who has had at least one previous experience with alcohol (at least 1 standard unit of alcohol, once in their lifetime)
* Having access to an internet network and a computer, tablet or telephone
* Written and informed consent of the parents and the teenager
Exclusion Criteria
* Moderate to Severe Adolescent Substance Use Disorders (other than smoking)
* Decompensated current psychiatric disorders in adolescents
* Already followed for severe use disorders and/or severe psychiatric disorders
* Nonunderstanding of the french language
14 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morgane GUILLOU - LANDREAT, Dr
Role: PRINCIPAL_INVESTIGATOR
CHRU Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loik JOUSNI
Brest, , France
Morgane GUILLOU - LANDREAT
Brest, , France
Pascale ROZEC
Landerneau, , France
Catherine SIMON
Morlaix, , France
Benoit SCHRECK
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Loik JOUSNI
Role: primary
Morgane GUILLOU - LANDREAT, Dr
Role: primary
Pascale ROZEC, Dr
Role: primary
Catherine SIMON, Dr
Role: primary
Benoit SCHRECK
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Guillou-Landreat M, Tahmazov E, Benoit S, Grall-Bronnec M, Conrod P, Livet A, Nowak E, Le Reste J-. The efficacy of a targeted PREVENTION programme for addictive behaviour (PREVENTURE) among vulnerable ADOlescents in France - study procotol. BMC Public Health. 2021 Apr 23;21(1):783. doi: 10.1186/s12889-021-10795-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC20.0114
Identifier Type: -
Identifier Source: org_study_id